# Traferox Technologies Inc. (manufacturer, Mississauga Ontario, CA): 3 new FDA device listings, incl. system, perfusion, kidney

**Score:** 85/100

| Field | Value |
|---|---|
| Establishment | Traferox Technologies Inc. |
| Role | Manufacturer |
| Establishment types | Manufacture Medical Device |
| Location | Mississauga Ontario, CA |
| New listings | 3 |
| Devices | System, Perfusion, Kidney; System And Accessories, Isolated Heart, Transport And Preservation; Normothermic Preservation System For Transplantation Of Initially Unacceptable Donor Lungs |
| Product codes | KDN, MSB, PHO |
| Device classes | Class II, Class III |
| Medical specialties | Gastroenterology, Urology |
| Brand names | VI°Port Liver Preservation System; X°Port Heart Preservation System; TorEx Lung Perfusion System; TorEx Lung Perfusate |
| First new listing | 2026-06-17 |
| Latest new listing | 2026-09-21 |
| FDA registration number | 3027669473 |
| Registration expires | 2026-12-31 |

## Why this score
- Brings its own devices to market: buys manufacturing, sterilization and QMS help.
- Class II or III devices: QMS and regulatory demands.
- Several new listings at once.
- Listed in the last 45 days.

Source: openFDA device registration and listing endpoint (U.S. Food and Drug Administration) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm). Last refreshed: 2026-10-28T20:51:27.468Z.
From the openFDA device registration and listing data, refreshed weekly. A listing shows a device an establishment says it makes or handles for the U.S. market; it is not FDA clearance or approval. Contact persons and street addresses are not stored. Verify in the FDA Establishment Registration and Device Listing database.